IDENTIFICATION OF RESPONDER AND DISEASE ACTIVITY THRESHOLDS FOR THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM TWO PHASE 3 TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS

被引：1
|
作者：
Gossec, L. [1 ,2 ]
Coates, L. [3 ]
Orbai, A. M. [4 ]
De Wit, M. [5 ]
Pelligra, C. [6 ]
Lambert, J. [7 ]
Ciaravino, V. [7 ]
Ink, B. [8 ]
Taieb, V. [7 ]
Gladman, D. D. [9 ]
机构：
[1] Sorbonne Univ, Paris, France
[2] Hop La Pitie Salpetriere, AP HP, Paris, France
[3] Univ Oxford, Nuffield Dept Orthopaed, Rheumatol & Musculoskeletal Sci, Oxford, England
[4] Johns Hopkins Univ, Div Rheumatol, Sch Med, Baltimore, MD USA
[5] Stichting Tools, Amsterdam, Netherlands
[6] Evidera, Medellin, Colombia
[7] UCB Pharma, Colombes, France
[8] UCB Pharma, Slough, Berks, England
[9] Univ Toronto, Schroeder Arthrit Inst, Krembil Res Inst, Toronto Western Hosp, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; Clinical trials; Patient reported outcomes; OUTCOME MEASURE; VALIDATION;
D O I：
10.1136/annrheumdis-2023-eular.1980
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0590-HP
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [1] PSYCHOMETRIC ASSESSMENT OF THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM THE PHASE 3 BE OPTIMAL AND BE COMPLETE TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Coates, L. C.
    Orbai, A. M.
    Pelligra, C.
    Lambert, J.
    Ciaravino, V
    Ink, B.
    Taieb, V
    Gladman, D. D.
    VALUE IN HEALTH, 2023, 26 (06) : S323 - S323
  • [2] BIMEKIZUMAB TREATMENT RESULTED IN CLINICALLY MEANINGFUL IMPROVEMENTS IN THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) SCORES USING POOLED RESULTS FROM TWO PHASE 3 TRIALS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Coates, L.
    Orbai, A. M.
    De Wit, M.
    Lambert, J.
    Ink, B.
    Taieb, V.
    Gladman, D. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1130 - 1130
  • [3] Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study
    Lopez-Medina, Clementina
    Gorlier, Clemence
    Orbai, Ana-Maria
    Coates, Laura C.
    Kiltz, Uta
    Leung, Ying-Ying
    Palominos, Penelope
    Canete, Juan D.
    Scrivo, Rossana
    Balanescu, Andra
    Dernis, Emmanuelle
    Meisalu, Sandra
    Ruyssen-Witrand, Adeline
    Soubrier, Martin
    Aydin, Sibel Zehra
    Eder, Lihi
    Gaydukova, Inna
    Lubrano, Ennio
    Kalyoncu, Umut
    Richette, Pascal
    Husni, M. Elaine
    Smolen, Josef S.
    de Wit, Maarten
    Gossec, Laure
    RHEUMATOLOGY, 2025,
  • [4] Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis
    Gossec, Laure
    Orbai, Ana-Maria
    Coates, Laura C.
    Gladman, Dafna D.
    Ogdie, Alexis
    Pelligra, Christopher G.
    Ciaravino, Valerie
    Ink, Barbara
    Taieb, Vanessa
    Lambert, Jeremy
    de Wit, Maarten
    RMD OPEN, 2024, 10 (01):
  • [5] Screening and disease activity assessment for psoriatic arthritis using the PEST and PsAID-12
    Ball, G.
    Hamade, H.
    Zundell, M.
    Merola, J.
    Shin, S.
    Senthilkumaran, T.
    Perez-Chada, L.
    Gottlieb, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S27 - S27
  • [6] CHANGE OF PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID12) QUESTIONNAIRE RELATED TO CHANGE IN DISEASE ACTIVITY IN EARLY PSORIATIC ARTHRITIS
    Wervers, K.
    Luime, J. J.
    Tchetverikov, I.
    Gerards, A. H.
    Kok, M. R.
    Appels, C. W. Y.
    van der Graaff, W.
    van Groenendael, J. H. L. M.
    Korswagen, L-A.
    Veris-van Dieren, J. J.
    Hazes, J. M. W.
    Vis, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1325 - 1325
  • [7] ANALYSIS OF THE PROGNOSTIC VALUE OF THE 12-ITEM PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID-12) QUESTIONNAIRE FOR EVALUATION OF PSORIATIC ARTHRITIS ACTIVITY(PSA) BY DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA) IN ROUTINE CARE: DATA OF THE RUSSIAN PSORIATIC ARTHRITIS REGISTRY(RU-PSART)
    Koltakova, Anastasia
    Loginova, Elena
    Gubar, Elena
    Korsakova, Yulia
    Korotaeva, Tatiana
    Sedunova, Maria
    Pristavsky, Igor
    Umnova, Irina
    Bondareva, Irina
    Kudishina, Snezana
    Nasonov, Evgeny
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1845 - 1846
  • [8] PREVALENCE OF METABOLIC SYNDROME IN BRAZILIAN PATIENTS WITH PSORIATIC ARTHRITIS AND ASSOCIATION OF OBESITY WITH THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID-12) - A MULTICENTER STUDY
    Ribeiro E Souza, Elziane Da Cruz
    Da Silva Carneiro, Sueli Coelho
    Alexandre Yazbek, Michel
    De Cassia Menin, Rita
    Barbosa Campanholo, Cristiano
    Nascimento Carneiro, Jamile
    Martins Da Silva, Carlos Henrique
    Ranza, Roberto
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S123 - S123
  • [9] Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Reductions in Disease Impact Assessed by the Psoriatic Arthritis Impact of Disease (PsAID)-12 Questionnaire: Up to 2-Year Results from Two Phase 3 Studies
    Gossec, Laure
    Gladman, Dafna
    Coates, Laura
    de Wit, Maarten
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Lambert, Jeremy
    Orbai, Ana-Maria
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1228 - 1232
  • [10] Psoriatic Arthritis Impact of Disease (PSAID12) in Early Psoriatic Arthritis: Pain As One of the Main Determinants of Disease Impact
    Wervers, Kim
    Luime, Jolanda J.
    Tchetverikov, Ilja
    Gerards, Andreas H.
    Kok, Marc R.
    Appels, Cathelijne W. Y.
    van der Graaff, Wiebo L.
    van Groenendael, Johannes H. L. M.
    Korswagen, Lindy-Anne
    Veris, Jozien
    Hazes, J. M. W.
    Vis, Marijn
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345